AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Medicare/Medicaid MMM
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors H.R. 4994, Medicare and Medicaid Extenders Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Budget/Appropriations BUD
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration H J Res 101, 2nd Continuing Resolution; H J Res 105, 3rd Continuing Resolution; HR 3028 FY 2011 Continuing Resolution through March 4, 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.